ERBB2 and breast carcinoma: Upon first inspection, we see vast differences in the performance of our models across subtype (Additional file 2: Figure S11), with a large majority of genes performing at EV R2 > 0.01 in rarer subtypes, like HER2-enriched breast cancers.